Phase 3 CLL/SLL Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Global Trial in APG2575 for Patients With CLL/SLL
CLL/SLL
Ascentage Pharma Group Inc.400 enrolled2 locationsNCT06104566
Recruiting
Phase 3
A Global Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.
CLL/SLL
Ascentage Pharma Group Inc.344 enrolled6 locationsNCT06319456